Abstract:Intravenous (IV) thrombolysis is currently the most established treatment for acute ischemic stroke 1. Traditionally, patients with unruptured intracranial aneurysms have been deemed ineligible due to a theoretical increased risk of intracranial hemorrhage (ICH) from post-thrombolytic rupture of aneurysm. Recently, four retrospective studies indicated no significant difference in symptomatic ICH after intravenous thrombolysis between stroke patients with or without intracranial aneurysms 2-5. However, in most of these patients, the ischemic stroke mechanism was unrelated to the unruptured intracranial aneurysm. The safety of IV thrombolysis in acute ischemic stroke in the same territory of unruptured intracranial aneurysms remains unknown. We therefore present a case of pontine infarction due to a large unruptured intracranial aneurysm (17 mm in diameter) of the basilar artery where the patient received IV recombinant tissue plasminogen activator (rtPA) thrombolysis based on multimodal MR imaging. A 59-year-old man was admitted to the emergency room with a 4-h history of abrupt-onset right hemiparesis and dysarthria. He reported that the symptom severity increased during transport to the hospital. The patient had a past medical history of treated hypertension for 20 years and known basilar artery aneurysm for 2 years that had been managed conservatively. His blood pressure was 160/102 mmHg on admission. Neurological examination revealed normal conscious state, dysarthria, right hemiparesis, and sensory loss. His score on the National Institutes of Health Stroke Scale (NIHSS) was 6. A brain magnetic resonance imaging (MRI) scan (3.0T) was performed immediately. Diffusion-weighted imaging (DWI) revealed increased signal intensity in the left ventral pons (Figure 1A), indicating the presence of hyperacute infarction. Magnetic resonance angiography (MRA) showed a large unruptured intracranial aneurysm of the basilar artery (17 mm in maximal diameter) without basilar artery occlusion (Figure 1B). IV rtPA was administered immediately at a dose of 0.9 mg/kg body weight. His focal neurological deficit dramatically improved by the next morning. Twenty-four hours later, he was also administered an antiplatelet agent (aspirin 200 mg). He made a complete recovery and was discharged 6 days later (NIHSS 0). Our patient did not have any evidence of aneurysm rupture or ICH on his initial susceptibility-weighted imaging (SWI) scan, or on computed tomographic (CT) scan 2 h after thrombolysis (Figure 1C), and SWI at 24 h. There was no evidence of atherosclerotic disease on cervical CT angiography or carotid duplex ultrasonography. Noncontrast and contrast-enhanced T1 fast spin echo (FSE) sequences demonstrated abnormal blood flow with partial thrombosis of the aneurysm (Figure 2A and B). We hypothesize that the abnormal flow within the aneurysm (Figure 2C) leads to gradual thrombosis. Approximately 9.3% of stroke patients receiving intravenous thrombolysis have incidental aneurysms 2. Sometimes the intracranial aneurysms which presence is already known either being managed conservatively or already treated with clipping or coil embolization. On other occasions, the aneurysm is diagnosed during multimodal imaging performed to investigate the stroke. In acute stroke patients with pre-existing intracranial aneurysms, recent studies have suggested that intravenous thrombolysis may be safe given the similar rates of hemorrhagic transformation 2-5 and favorable 3-month clinical outcomes 5. There has been one report of anterior-communicating artery aneurysm rupture after IV rtPA for acute ischemic stroke 6. However, this case may have had a sentinel bleed from an intracranial aneurysm before the onset of ischemic stroke symptoms. Thus, it does highlight the necessity of carefully excluding previous aneurysm rupture before the administration of rtPA. Symptomatic acute ischemia in the territory of an unruptured intracranial aneurysm occurs rarely (approximately 1.3% of ischemic stroke patients) 7. Only two patients who have received thrombolysis in this context have been previously reported. One patient had a left middle cerebral artery aneurysm and received intravenous rtPA for their stroke 8. The other had a basilar tip aneurysm, and the stroke was treated with delayed intra-arterial rtPA 9. The largest aneurysms reported in patients who received rtPA have been approximately 8 mm in diameter 2, 3. Our case is the first report of acute ischemic stroke associated with an unruptured large intracranial aneurysm (17 mm diameter) of the basilar artery with successful treatment using IV rtPA. According to multimodal imaging analysis, thrombus was clearly observed in the aneurysm of the basilar artery. We hypothesize that the pontine infarct may have a potential association with the thrombus in the aneurysm. The fresh extension of intraluminal thrombus may have had lower platelet content, making it more susceptible to pharmacological thrombolysis. In conclusion, whilst it is difficult to estimate the risk of ICH after thrombolysis in acute ischemic stroke patients associated with intracranial aneurysms, our case indicates that at least some patients may benefit from IV rtPA. This case also suggests that multimodal imaging may assist physicians to identify the stroke mechanism and predict response to thrombolytic therapy. Dr. Lou receives research support from Zhejiang Provincial Natural Science Foundation of China (LR12H09001), the National Natural Science Foundation of China (81171095), and the Health Bureau of Zhejiang Province (WKJ2010-2-010). We thank Prof. Bruce Campbell (Royal Melbourne Hospital, University of Melbourne, Parkville, Vic., Australia) for English language correction. The authors have no actual or potential conflicts of interest to disclose.

“Sudden Drop” in Blood Pressure is Associated with Recanalization after Thrombolysis

Relationship Between Early Blood Pressure Variability and Reperfusion in Acute Ischemic Stroke Patients with Intravenous Thrombolysis

Late recanalisation beyond 24 hours is associated with worse outcome: an observational study

Systolic Blood Pressure Variability is Associated with Severe Hemorrhagic Transformation in the Early Stage after Thrombolysis.

New microbleeds after thrombolysis: contiguous thin-slice 3T MRI.

Non-atrial Fibrillation Was Associated with Early Neurological Improvement after Intravenous Thrombolysis with Rt-Pa in Patients with Acute Ischemic Stroke

Abstract W P43: Extent of “blooming Effect” Predicts Middle Cerebral Artery Recanalization after Intravenous Thrombolysis

Corticospinal Tract Hypoperfusion Associated with Unexplained Early Neurological Deterioration after Intravenous Thrombolysis.

Hypoperfusion In Lenticulostriate Arteries Territory Related To Unexplained Early Neurological Deterioration After Intravenous Thrombolysis

Time-dependent Infarct Volume Affects the Benefit of Recanalization.

The Blood Pressure Paradox in Acute Ischemic Stroke.

Slow Collateral Flow Is Associated with Thrombus Extension in Patients with Acute Large-Artery Occlusion.

Maximal Infarct Volume to Benefit from Intravenous Thrombolysis and Its Relation with Onset to Treatment Time

No Hemorrhagic Transformation after Intravenous Thrombolysis in a Pontine Infarction Patient with Basilar Aneurysm.

The velocity of collateral filling predicts recanalization in acute ischemic stroke after intravenous thrombolysis

Blood pressure undulation of peripheral thrombolysis period in acute ischemic stroke is associated with prognosis

The Relationship between Blood Pressure Variability, Recanalization Degree, and Clinical Outcome in Large Vessel Occlusive Stroke after an Intra-Arterial Thrombectomy

Effects of Early Changes in Blood Pressure During Intravenous Thrombolysis on the Prognosis of Acute Ischemic Stroke Patients

Timeline of blood pressure changes after intra-arterial therapy for acute ischemic stroke based on recanalization status

Association of maximal systolic blood pressure with poor outcome in patients with hyperattenuated lesions on immediate NCCT after mechanical thrombectomy.